SciELO - Scientific Electronic Library Online

 
vol.32 issue4IDEA Study (International Day for the Evaluation of Abdominal Obesity): Primary care study of the prevalence of abdominal obesity and associated risk factors in Colombia author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Biomédica

Print version ISSN 0120-4157

Abstract

VILLA-CAMACHO, Juan Carlos; VARGAS-ZAMBRANO, Juan Camilo  and  GONZALEZ, John Mario. Modelo de detección de anticuerpos neutralizantes contra IFN-β mediante citometría de flujo. Biomédica [online]. 2012, vol.32, n.4, pp.617-622. ISSN 0120-4157.  https://doi.org/10.7705/biomedica.v32i4.637.

Introduction. Interferon beta (IFN-β) is a treatment for relapsing remitting multiple sclerosis. However, the therapeutic use of recombinant proteins induces a humoral immunologic response resulting in the induction of binding (BAb) or neutralizing (NAb) antibodies against the biological product. The presence of neutralizing antibodies has been associated with decreased IFN-β treatment efficacy. Materials and methods. Two tumor cell lines (K562 and U937) were cultivated with human recombinant IFN-β1a at different concentrations and lengths of time in order to measure the expression of intracellular ISG15, an inducible molecule in the IFN-β1a signaling cascade. Blood was obtained from non-immunized and IFN-β1a immunized (100,000 IU) New Zealand rabbits. The presence of BAb was evaluated by ELISA. For NAb detection, sera 1:20 dilution were added to the IFN-β1a-stimulated cell lines, and ISG15 expression was evaluated by flow cytometry. Results. K562 cells provided the better cell line for the assay, stimulated with a dose of 1,000 IU of IFN-β1a, and a 1:100 dilution for the primary antibody and a 1:200 dilution for the secondary antibody. ISG15 expression was compared between cells alone or cultivated with IFN-β1a. Mean fluorescence intensity (MFI) for ISG-15 expression median was 198 arbitrary units (AU) with interquartile ranges of 173-231 AU for non-stimulated cells and 430 AU with interquartile ranges of 316-611.5 AU for IFN-β1a stimulated cells (p<0.01). Immunized rabbit sera decreased the expression of ISG-15 in K562 cells stimulated with IFN-β1a, whereas non-immunized rabbit sera did not. Conclusions. This rabbit model demonstrates that ISG15 expression evaluated with flow cytometry can be used as a detection assay for NAb.

Keywords : Antibodies, neutralizing; K562 cells; flow cytometry; multiple sclerosis; interferon-beta.

        · abstract in English | Spanish     · text in Spanish     · Spanish ( pdf )